Varun Srinivas
The first two weeks of January 2026 sent shockwaves through the healthcare AI ecosystem. Within days of each other, the world's most influential AI companies made their intentions unmistakably clear: healthcare is the next frontier, and they're coming for it with full force.
OpenAI launched ChatGPT Health on January 7th, a dedicated experience allowing users to connect their medical records, wellness apps, and wearable data for personalized health guidance. The company revealed that over 230 million people globally ask health-related questions on ChatGPT every week. Just days later, Anthropic announced Claude for Healthcare at the J.P. Morgan Healthcare Conference, introducing HIPAA-ready infrastructure with connectors to Medicare databases, ICD-10 coding systems, and clinical trial platforms. Google, meanwhile, continues advancing MedGemma, its open-source medical AI model family, achieving 91.1% accuracy on the MedQA benchmark.
For the hundreds of healthcare AI startups that have collectively raised billions in venture capital, this raises an existential question: can they survive when the world's most powerful AI companies are building directly competitive products?